BRAIN Biotech AG (BNN.DE)
- Previous Close
2.0600 - Open
2.0200 - Bid --
- Ask --
- Day's Range
2.0200 - 2.1200 - 52 Week Range
1.4150 - 4.4000 - Volume
3,211 - Avg. Volume
7,235 - Market Cap (intraday)
45.224M - Beta (5Y Monthly) 0.78
- PE Ratio (TTM)
-- - EPS (TTM)
-0.5700 - Earnings Date May 28, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
5.99
BRAIN Biotech AG provides bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. It operates through three segments: BioProducts, BioScience, and BioIncubator. The company offers enzymes, biocatalysts, microorganisms, and other bioactive natural compounds to produce foodstuffs and animal feed, cosmetics, and medical products, as well as for industrial applications in chemical companies, waste and hazardous materials disposal, and energy and raw materials production. The company was formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG and changed its name to BRAIN Biotech AG in April 2021. The company was founded in 1993 and is headquartered in Zwingenberg, Germany.
www.brain-biotech.com296
Full Time Employees
September 30
Fiscal Year Ends
Sector
Industry
Recent News: BNN.DE
View More
Performance Overview: BNN.DE
Trailing total returns as of 5/12/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BNN.DE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BNN.DE
View MoreValuation Measures
Market Cap
45.01M
Enterprise Value
30.52M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.82
Price/Book (mrq)
4.98
Enterprise Value/Revenue
0.55
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-22.42%
Return on Assets (ttm)
-8.19%
Return on Equity (ttm)
-81.22%
Revenue (ttm)
55.82M
Net Income Avi to Common (ttm)
-12.52M
Diluted EPS (ttm)
-0.5700
Balance Sheet and Cash Flow
Total Cash (mrq)
17.82M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
826.62k